Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled colistimethate sodium for non-cystic fibrosis bronchiectasis with chronic Pseudomonas aeruginosa infection
2015-002743-33Phase 3Unknown
- Sponsor
- Zambon
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bronchiectasis and Pseudomonal infection comparing Colistimethate sodium with Placebo (2 arms). Primary endpoint: Frequency of pulmonary exacerbations. Status: unknown.
02
Drugs
colistimethate sodium
03
Conditions
bronchiectasisPseudomonal infection
Beyond the preview
Go deeper on 2015-002743-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002743-33.